NEWS

 

Brinson Patrick News

Recent News Releases

View All »

04.10.2014 – Brinson Patrick News Release
Brinson Patrick Re-launches Research Department
Firm Initiates Coverage on Corcept Therapeutics, Ligand Pharmaceuticals, MannKind Corporation, Opexa Therapeutics and Rexahn Pharmaceuticals

10.04.2013 – Brinson Patrick News Release
U.S. Companies Raised $4.3 Billion with At-the-Market (ATM) Offerings in Second Quarter of 2013
Quarter-Over-Quarter Increase is 43% vs. $3.0 Billion Raised in the First Quarter

09.17.2013 – Brinson Patrick News Release
Record Use of At-the-Market (ATM) Offerings by U.S. Life Sciences Companies in First Half of 2013
Life Sciences Industry Raised $108 Million in Q2 and $285 Million in First Half

09.11.2013 – Brinson Patrick News Release
Brinson Patrick Professionals to Operate New Division of Meyers Associates
Division will offer broad set of investment banking services

09.02.2013 – Growth Capital Investor
ATM Deals Grow While Registered Directs and CMPOs Stagnate
The number of ATM offerings continues to grow

06.05.2013 – Brinson Patrick News Release
U.S. Companies Raised $3 Billion with At-the-Market (ATM) Offerings in First Quarter of 2013, Reports Brinson Patrick
Quarter-Over-Quarter Increase is 90% vs. $1.6 Billion Raised in the Fourth Quarter 2012

05.28.2013 – Brinson Patrick News Release
Record Use of At-the-Market (ATM) Offerings Continues in 2013 with $161 Million Raised by U.S. Life Sciences Companies in First Quarter
Quarter-Over-Quarter Increase is 25 Percent vs. $129 Million Raised by Life Sciences Companies in the Fourth Quarter of 2012

04.29.2013 – Brinson Patrick News Release
Brinson Patrick Reports $9 Billion Raised by U.S. Companies Through At-The-Market (ATM) Offerings in 2012
Year-Over-Year Increase is 13 Percent vs. $8.1 Billion Raised in 2011

04.08.2013 – Brinson Patrick News Release
Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick
Record High Usage of ATMs in 2012 by U.S. Life Sciences Companies

09.19.2012 – Brinson Patrick News Release
Brinson Patrick Reports $2.1 Billion Raised by U.S. Companies Through 133 At-the-Market (ATM) Offerings in Q2 2012
57 ATM Agreements were Signed in the Second Quarter of 2012

09.06.2012 – Brinson Patrick News Release
Brinson Patrick Reports $45 Million Raised by U.S. Life Sciences Companies Through 12 At-the-Market (ATM) Offerings in Q2 2012
Total Raised in First Half of 2012, $136 Million, an Increase Over Same Period in 2011

09.05.2012 – Brinson Patrick News Release
Brinson Patrick Expands Equity Research Department with Addition of Senior Analyst Vernon Bernardino
Bernardino Brings 11 Years of Experience Covering Life Sciences Companies to Investment Bank

07.18.2012 – Brinson Patrick News Release
Brinson Patrick Adds Kevin Tyler to Healthcare Investment Banking Team
Boutique Bank Specializing in At-the-Market Offerings Relocates West Coast Office to Newport Beach, California

06.05.2012 – Brinson Patrick News Release
140 At-the-Market Offerings raise $2.3 Billion Q1 2012, Brinson Patrick Reports
Dollars Raised Increased by 121 Percent from Fourth Quarter of 2011, 6.5 Percent from Same Quarter Last Year

05.24.2012 – Brinson Patrick News Release
Brinson Patrick Reports Record $90 Million Raised by U.S. Life Sciences Companies Through 20 At-the-Market (ATM) Offerings in First Quarter This Year
ATM Usage is Highest Recorded in Healthcare Industry Segment

Recent Press Coverage

View All »

02.27.2013 – Reuters
Bank Fees Drop
U.S. companies change way they sell stock

02.04.2013 – Growth Capital Investor
ATM Offerings and Equity Lines
Three Differences Issuers Need to Understand

12.17.2012 – BioWorld Insight
Popularity of ATMs Continues to Grow
Use of ATM offerings by life sciences companies reached a record high in the third quarter

10.01.2012 – Growth Capital Investor
ATMs On the Rise
The rapid growth of ATM issuance is clear evidence that management teams consider ATMs a great idea

10.01.2012 – Genetic Engineering & Biotechnology News
Advice to Biofirms: Be Prepared, Plan Ahead
Article features Robert E. Hoffman, CFO of Arena Pharmaceuticals (NASDAQ: ARNA)

09.25.2012 – MedCity News
ATM Offerings Provide Alternative Approach to Raising Capital
Article features Christopher J. Reinhard, CEO and Chairman of Cardium Therapeutics (NYSE MKT: CXM)

08.20.2012 – BioWorld Insight
ATM Financing Provides Effective Access to Cash
Handy Tool for CFOs

08.01.2012 – Life Science Leader
Raising Life Sciences Capital: An Alternative Way
There are various strategies public life sciences companies use to raise equity capital

07.19.2012 – MedCity News
Common Misunderstandings of an Emerging Financing Vehicle: At-the-Market Offerings
Strategic CFOs in the life sciences industry are increasingly employing ATMs because they enable companies to better control the financing process and the relatively low cost compared to more traditional follow-on financing vehicles.

07.01.2012 – Genetic Engineering & Biotechnology News
Dispelling ATM Offering Myths
Better Control of Financing Process Enabled by Increasingly Popular At-the-Market Offerings

Media Kit

Company Profile, Contacts and more.
View the Media Kit »

Brinson Patrick acts as a facilitator to sell the shares. We set the price so the program was as customizable as we wanted.”

VP Investor Relations,
Life Sciences Firm

Get Brinson Patrick News Updates and Alerts »